Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation (CTX)
This study is ongoing, but not recruiting participants.
Sponsor:
Columbia University
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Elizabeth Shane, Columbia University
ClinicalTrials.gov Identifier:
NCT00297830
First received: February 27, 2006
Last updated: February 11, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2014 |
| Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |